N-methyl-4-phenylpyridinium scaffolds containing lipophilic compounds are potent complex i inhibitors and selective dopaminergic toxins

No Thumbnail Available
Authors
Lickteig, Bryan
Wimalasena, Virangika K.
Wimalasena, Kandatege
Issue Date
2019-04-01
Type
Article
Language
en_US
Keywords
Dopaminergic toxins , Environmental toxins , MPP + derivatives , Parkinson's disease , Reactive oxygen species , Complex Inhibitors
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract

Although the exact cause or causes of Parkinson's disease (PD) are not fully understood, it is believed that environmental factors play a major role. The discovery that a synthetic chemical, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-derived N-methyl-4-phenylpyridinium (MPP + ), recapitulates major pathophysiological characteristics of PD in humans has provided the strongest support for this possibility. While the mechanism of the selective dopaminergic toxicity of MPP + has been extensively studied and is, in most respects, well accepted, several key aspects of the mechanism are still debatable. In the present study, we use a series of structurally related, novel, and lipophilic MPP + derivatives [N-(2-phenyl-1-propene)-4-phenylpyridinium] to probe the mechanism of action of MPP + using dopaminergic MN9D and non-neuronal HepG2 cells in vitro. Here we show that effective mitochondrial complex I inhibition is necessary and that the specific uptake through plasma membrane dopamine transporter is not essential for dopaminergic toxicity of MPP + and related toxins. We also provide strong evidence to support our previous proposal that the selective vulnerability of dopaminergic cells to MPP + and similar toxins is likely due to the high inherent propensity of these cells to produce excessive reactive oxygen species as a downstream effect of complex I inhibition. Based on the current and previous findings, we propose that MPP + is the simplest of a larger group of unidentified environmental dopaminergic toxins, a possibility that may have major public health implications.

Description
Click on the DOI link to access the article (may not be free).
Citation
Lickteig, Bryan; Wimalasena, Virangika K.; Wimalasena, Kandatege. 2019. N-methyl-4-phenylpyridinium scaffolds containing lipophilic compounds are potent complex i inhibitors and selective dopaminergic toxins. ACS Chemical Neuroscience 2019
Publisher
ACS
License
Journal
Volume
Issue
PubMed ID
DOI
ISSN
1948-7193
EISSN